By Sheila R. Plant, Ph.D., R.A.C., Regulatory Scientist at Cato Research FDA draft and final guidances, released from CDER, CBER, and CDRH in October are posted. In addition, upcoming Advisory committee meetings are listed below with links to more information on … Continue reading
The post New FDA Guidances for October 2014 & Critical Path Innovation Meetings appeared first on Ask Cato.
